LONDON--(BUSINESS WIRE)--The Global Pharmaceutical Formulation market will register an incremental spend of about $183 billion, growing at a CAGR of 6.23% during the five-year forecast period. A ...

LONDON--(BUSINESS WIRE)--The Pharmaceutical Formulation Equipment market will register an incremental spend of about USD 7.35 billion, growing at a CAGR of 8.42% during the five-year forecast period.

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

CDMOs are expanding to provide integrated services, enhancing outsourcing appeal. Sustainability mandates boost adoption of advanced systems, and growth is pronounced in excipient innovation and ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

Wu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations ...

How does the law remain favorable toward the validity of chemical and pharmaceutical formulation patents? Join Partner Justin Hasford of Finnegan, Henderson, Farabow, Garrett & Dunner as he explores ...

Xiaoping Wu of Wanhuida Intellectual Property explains how the CNIPA’s recent invalidation of a sustained-release patent illustrates key considerations in assessing inventive step for pharmaceutical ...

An innovative digital platform for solid dosage form design and development that reduces time and effort from core to coating. HARLEYSVILLE, Pa., June 21, 2023 /PRNewswire/ -- Colorcon Inc. announces ...

Type-3 New Drug Applications, focusing on new dosage forms, dominate the 505(b)(2) pathway approvals, with injectable formulations being the largest category. Stability and manufacturing consistency ...